Has Pratik Sandesara, MD received payments from drug or device companies?

Yes. Drug and device makers reported $367,039 in general payments to Pratik Sandesara, MD across 506 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Pratik Sandesara, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Pratik Sandesara, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Pratik Sandesara, MD

Interventional Cardiology · Atlanta, GANPI 1033452354

Payments from drug & device makers

$367,039in general payments, 2019–2025

Across 506 payments — averaging $725.37 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Medtronic$129K
Boston Scientific$86K
Shockwave Medical, Inc$55K
Arrow International, Inc.$35K
Penumbra, Inc.$32K
Asahi Intecc USA, Inc.$11K
plus $19K from 14 others

What the payments were for

Consulting fees$4,7383%
Speaking & faculty fees$103,74663%
Travel & lodging$31,36019%
Food & beverage$25,21215%
Education$720%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Medtronic	102	$129,431
Boston Scientific	163	$85,845
Shockwave Medical, Inc	29	$54,819
Arrow International, Inc.	1	$34,602
Penumbra, Inc.	57	$32,419
Asahi Intecc USA, Inc.	37	$10,535
Abbott	42	$9,059
Abiomed	27	$4,538
Inari Medical, Inc.	11	$1,982
Edwards Lifesciences	5	$910
W. L. Gore & Associates, Inc.	11	$789
Heartflow, Inc.	2	$683
Teleflex LLC	4	$468
Cardiva Medical, Inc.	3	$274
Philips North America LLC	6	$236
Recor Medical Inc	1	$180
Thrombolex, Inc.	1	$120
Verge Medical, Inc.	1	$88
Kestra Medical Technology Services, Inc.	1	$31
Angiodynamics, Inc.	2	$31

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

GENERAL VASCULAR ACCESS$71,617
Indigo System$31,533
RESOLUTE ONYX$7,922
PERIPHERAL VASCULAR$6,770
ONYX FRONTIER$5,734
DRAGONFLY OPSTAR$4,589
Impella$3,636
ASAHI PTCA Guide Wire$2,629
GENERAL - THERAPIES$2,498
XIENCE SKYPOINT$2,093
FLOWTRIEVER CATHETER, S$1,953
CT THROMBECTOMY SYSTEM KIT$1,743
AVVIGO Guidance System$1,397
Shockwave IVL System with the Shockwave C2 Coronary IVL Catheter$1,115
FFRct$683
ROTAPRO$677
General - Balloon Catheters$625
OPTIS$585
OPTICROSS$527
Edwards SAPIEN 3 Ultra Transcatheter Heart Valve$508

How this compares

$367,039 in reported general payments places this provider in the 85th percentile of 218 interventional cardiology providers in Georgia.

See all interventional cardiology providers in Georgia →

Medicare billing

Part B allowed, 2024

$208,413

Medicare patients

345

Services billed

1,293

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
EliquisApixaban	94	$91,668
EntrestoSacubitril/Valsartan	41	$44,769
FarxigaDapagliflozin Propanediol	30	$41,976
BrilintaTicagrelor	56	$37,750
JardianceEmpagliflozin	24	$21,888
Repatha SureclickEvolocumab	16	$9,724
ClopidogrelClopidogrel Bisulfate	446	$4,545
Ranolazine ErRanolazine	69	$4,203
Prasugrel Hcl	32	$2,151
Atorvastatin Calcium	199	$1,810
Isosorbide Mononitrate ErIsosorbide Mononitrate	133	$1,661
Metoprolol Succinate	128	$1,173
Carvedilol	91	$636
Rosuvastatin Calcium	67	$599
Pantoprazole Sodium	56	$520

Paid to pharmacies, not to this prescriber.

Other interventional cardiology in Atlanta

David KandzariAtlanta$3.7M
Pradeep YadavAtlanta$3.5M
Vasilis BabaliarosAtlanta$2.7M
William NicholsonAtlanta$2M
Chandanreddy DevireddyAtlanta$1.9M
Adam GreenbaumAtlanta$1.8M
Vivek RajagopalAtlanta$1.3M
Christopher MeduriAtlanta$1.1M
Wissam JaberAtlanta$981K
George HanzelAtlanta$750K

See the full list for Georgia →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →